Inactive Instrument

Highlights E-Qure Corp. Other OTC

Equities

EQUR

US26885P1093

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

E-Qure Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	22-01-13	CI
E-Qure Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-07-06	CI
E-Qure Corp. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-30	CI
E-Qure Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-13	CI
E-Qure Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-09-17	CI
E-Qure Corp. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-06-25	CI
E-Qure Corp. Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-13	CI
E-Qure Corp. Reports Material Updates Regarding Bioelectrical Signal Therapy Device	20-01-21	CI
E-Qure Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-14	CI
E-Qure Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-14	CI
E-Qure Corp. Reports Earnings Results for the Full Year Ended December 31, 2018	19-04-16	CI
E-Qure Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2018	19-01-02	CI
E-Qure To Seek Acquisitions	17-09-07	CI
U.S. FDA Approves Increase in Number of Clinical Sites for E-Qure Corp.'s Pivotal Trial of BST Device for the Treatment of Chronic Wound Care	17-02-23	CI
E-Qure Corp. Signs a Distribution Agreement with Tech - Médica Equipos Médicos S.A.S. in Colombia for its Patented Bio-Electrical Signal Therapy Device	17-01-18	CI
E-QURE Secures Investigational Device Exemption Approval from US Food and Drug Administration to Begin the Clinical Trial of Bio-Electrical Signal Therapy Device	16-11-03	CI
E-Qure Corp. Enters into Distribution Agreement with Chemipal Ltd	15-07-30	CI
E-Qure Corp. Signs First Distribution Agreement with Rubifarm S.A	15-06-10	CI
E-Qure Corp. completed the acquisition of Bioelectrical Signal Therapy device assets from Michael Cohen.	14-10-15	CI
E-Qure Corp. agreed to acquire Bioelectrical Signal Therapy device assets from Michael Cohen for $0.35 million.	14-10-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights E-Qure Corp. Other OTC

Equities

EQUR

US26885P1093

Highlights

Filters